Analystreport

Mesoblast (NASDAQ:MESO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Mesoblast Limited - American Depositary Shares  (MESO) 
US:NASDAQ Investor Relations: investorsmedia.mesoblast.com